Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Beam Therapeutics Inc.(BEAM) | 5,443,039 | 4,834,653 | -608,386 | $127.53M | $118.45M | 45.46% | -$9.08M |
| Rapport Therapeutics, Inc.(RAPP) | 3,728,738 | 3,728,738 | 0 | $86.73M | $76.36M | 29.31% | -$10.37M |
| Erasca, Inc.(ERAS) | 11,055,554 | 11,055,554 | 0 | $26.09M | $30.18M | 11.58% | +$4.09M |
| Q32 Bio Inc.(QTTB) | 320,482 | 320,482 | 0 | $5.75M | $14.30M | 5.49% | +$8.55M |
| Verve Therapeutics, Inc. | 2,008,809 | 2,008,809 | 0 | $9.80M | $9.72M | 3.73% | -$80.4K |
| Gossamer Bio, Inc.(GOSS) | 8,055,916 | 8,055,916 | 0 | $7.26M | $7.95M | 3.05% | +$688.8K |
| Singular Genomics Systems, Inc. | 126,630 | 126,630 | 0 | $1.07M | $1.98M | 0.76% | +$914.3K |
| Unity Biotechnology, Inc. | 1,004,817 | 1,004,817 | 0 | $1.36M | $1.48M | 0.57% | +$120.6K |
| CERo Therapeutics Holdings, Inc.CL A(CERO) | 1,444,296 | 1,444,296 | 0 | $431.8K | $134.8K | 0.05% | -$297.1K |